Methiothepin Suppresses Human Ovarian Cancer Cell Growth by Repressing Mitochondrion-Mediated Metabolism and Inhibiting Angiogenesis In Vivo

Pharmaceutics
Jin-Young LeeGwonhwa Song

Abstract

Ovarian cancer is the fifth leading cause of cancer-related deaths in women. Despite treatment, most patients experience relapse and the 5-year survival rate of ovarian cancer is less than 50%. Serotonin has cell growth-promoting functions in a variety of carcinomas, but the effect of serotonin receptor antagonists on ovarian cancer cells is unknown. In this study, it was confirmed that methiothepin, a serotonin receptor antagonist, suppresses the viability of, and induces apoptosis in, ovarian cancer cells. Methiothepin also induces mitochondrial dysfunction, represented by depolarization of the mitochondrial membrane and increased mitochondrion-specific Ca2+ levels, and causes metabolic disruption in cancer cells such as decreased ATP production and oxidative phosphorylation. Methiothepin also interferes with vascular development in transgenic zebrafish embryos. Combination treatment with methiothepin improves the anti-cancer effect of paclitaxel, a standard chemotherapeutic agent. In conclusion, this study revealed that methiothepin is a potential novel therapeutic agent for ovarian cancer treatment.

References

Nov 1, 1995·Journal of Clinical Epidemiology·A B Steingart, M Cotterchio
May 1, 1997·The American Journal of Physiology·B L Fanburg, S L Lee
Jul 2, 2003·Nature Reviews. Cancer·Roshan Agarwal, Stan B Kaye
Jul 3, 2003·Nature Reviews. Molecular Cell Biology·Sten OrreniusPierluigi Nicotera
Dec 12, 2003·Nature·Joseph T OpfermanStanley J Korsmeyer
Dec 20, 2003·Cell Death and Differentiation·S Oyadomari, M Mori
Apr 4, 2006·Biochemical and Biophysical Research Communications·Brigitte SonierCathy Vaillancourt
Jul 24, 2007·Trends in Pharmacological Sciences·Annette Gilchrist
May 15, 2008·Chemical Reviews·David E Nichols, Charles D Nichols
Jun 14, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Nicole ArbourRuth S Slack
Sep 9, 2008·Cell·Peggy P Hsu, David M Sabatini
Jan 1, 2005·Nonlinearity in Biology, Toxicology, Medicine·N Debbie SlamonVic W Pentreath
Dec 22, 2009·The Journal of Biological Chemistry·Jane L ArmstrongChristopher P F Redfern
Sep 2, 2010·American Journal of Clinical Oncology·Brijesh M MadhokDavid G Jayne
May 18, 2012·Cancer Research·Els M J J Berns, David D Bowtell
Aug 17, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Fiona SimpkinsJoyce M Slingerland
Jan 22, 2013·CA: a Cancer Journal for Clinicians·Rebecca SiegelAhmedin Jemal
Jul 17, 2013·Experimental Biology and Medicine·Ian S ZagonPatricia J McLaughlin
Aug 21, 2013·Pharmacological Reports : PR·Beata GrygierMichael Maes
Apr 26, 2014·Expert Opinion on Biological Therapy·Meghna TalekarMansoor Amiji
Dec 30, 2014·Cancer Metastasis Reviews·Hyun-Jin ChoiAnil K Sood
Apr 29, 2016·Oncotarget·Desiré K ChristensenSusan K Lutgendorf
Aug 17, 2016·International Journal of Molecular Sciences·Rachel Bar-ShavitBeatrice Uziely
Feb 6, 2017·Oncotarget·Charlotte TaylorAhmed Ashour Ahmed
Aug 10, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jin LiuPatricia Forgez
Aug 10, 2017·International Journal of Cancer. Journal International Du Cancer·Lina S MørchSusanne K Kjaer
Sep 19, 2018·International Journal of Cancer. Journal International Du Cancer·Susmita MondalViji Shridhar
Nov 6, 2018·Hematology/oncology Clinics of North America·Neesha C Dhani, Amit M Oza

❮ Previous
Next ❯

Methods Mentioned

BETA
chemical treatments
flow cytometry
protein assay
transgenic

Software Mentioned

ReViSP

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis